按類型、治療用途、最終用戶和地區分類的細胞激素市場

2025 年全球細胞激素市場規模估計為 988.4 億美元，預計到 2032 年將達到 1,785 億美元，2025 年至 2032 年的複合年成長率為 8.8%。

數字。 2025年各地區細胞激素市場佔有率（%）

細胞激素是細胞訊號蛋白，對控制和調節免疫和發炎反應很重要。細胞激素可作為免疫細胞之間的橋樑，作為免疫反應的一部分介導或調節免疫和發炎。隨著慢性發炎性疾病、癌症和感染疾病的日益流行，對用於診斷目的的細胞激素檢測的需求正在顯著成長。重組DNA技術的進步使得各種類型的細胞激素能夠大規模生產，從而推動了市場的成長。然而，在預測期內，與細胞激素研究相關的高成本可能會在一定程度上抑制市場擴張。

市場動態：

慢性疾病和危及生命的疾病盛行率的增加是推動細胞激素市場成長的主要因素。主要的市場促進因素包括全球癌症和感染疾病的增加。全球癌症患者數量估計為 1,930 萬，預計到 2020 年將有 1,000 萬人死亡。同樣，COVID-19、結核病等感染疾病也推動新診斷和治療方法的需求，包括細胞激素分析。此外，政府和私人組織增加對細胞激素研究的資助的舉措為市場參與者創造了有利可圖的機會。然而，高生產成本和細胞激素生產技術的技術限制繼續阻礙市場潛力。此外，細胞激素的保存期限短、穩定性差，對其更廣泛的商業化構成了挑戰。

本研究的主要特點

本報告對全球細胞激素市場進行了詳細分析，並提供了預測期（2025-2032）的市場規模（十億美元）和年複合成長率（CAGR%），假設基準年為 2024 年。

它還強調了各個領域的潛在商機，並說明了該市場的有吸引力的投資提案矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。

根據公司亮點、產品系列、關鍵亮點、績效和策略等參數，對全球細胞激素市場的主要企業進行分析。

研究涉及的主要企業包括雅培 (Abbott)、AB Sciex、安捷倫科技公司 (Agilent Technologies Inc.)、bioMerieux SA、Bio-Rad Laboratories Inc.、DiaSorin SpA、F. Hoffmann-La Roche Ltd.、Quest Diagnostics Inc.、丹納赫 (Danaher)、Danaoo, Spanos Ltd.、Dornostics Inc.、Yanah、Ianaher)、DiaSoticA.a]。

本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。

全球細胞激素市場報告迎合了該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。

相關人員可以透過分析全球細胞激素市場所使用的各種策略矩陣來簡化決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要

第3章市場動態、法規與趨勢分析

• 市場動態
• 影響分析
• 主要亮點
• 監管情景
• 產品發布/核准
• PEST分析
• 波特分析
• 併購場景

第4章。 2020-2032 年細胞激素市場（按類型分類）（十億美元）

• 腫瘤壞死因子
• 白細胞介素-II
• 干擾素-IFN
• 表皮生長因子（EGF）
• 其他

第5章。細胞激素市場，依治療應用，2020-2032 年（十億美元）

• 癌症
• 氣喘
• 關節炎
• 血液學
• 其他

第6章。細胞激素市場，按最終用戶分類，2020-2032 年（十億美元）

• 醫院
• 研究實驗室
• 其他

第 7 章細胞激素市場，按地區，2020-2032 年，價值（十億美元）

• 北美洲
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東
• 非洲

第8章競爭格局

• Abbott
• AB Sciex
• Agilent Technologies Inc.
• bioMerieux SA
• Bio-Rad Laboratories Inc.
• DiaSorin SpA
• F.Hoffmann-La Roche Ltd.
• Quest Diagnostics Inc
• Danaher
• DiaSorin SpA
• Immunodiagnostic Systems
• Fujirebio, Inc.

第9章分析師建議

• 機會
• 分析師觀點
• Coherent Opportunity Map

第10章參考文獻與調查方法

• 參考
• 調查方法
• 關於出版商

Global Cytokine Market is estimated to be valued at USD 98.84 Bn in 2025 and is expected to reach USD 178.50 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032.

Figure. Cytokine Market Share (%), By Region 2025

Cytokines are cell-signalling proteins that are crucial for controlling and regulating immune responses and inflammatory reactions. They act as the bridge intermediaries between immune cells and mediate or regulate immunity and inflammation as part of immune response. With the increasing prevalence of chronic inflammatory diseases, cancer, and infectious diseases, the demand for cytokine assays for diagnostic purposes has been growing significantly. Advancements in recombinant DNA technology have enabled mass production of different types of cytokines, thus aiding market growth. However, high costs associated with cytokine research may restrain market expansion to some extent over the forecast period.

Market Dynamics:

Increasing incidence of chronic and life-threatening diseases is a key factor driving the cytokine market growth. Some of the major market drivers include rising cases of cancers and infectious diseases globally. , the global cancer burden has risen to 19.3 million cases and 10 million cancer deaths in 2020. Similarly, infectious diseases like COVID-19, tuberculosis, etc. have surged the need for new diagnostic and therapeutic approaches including cytokine profiling. Further, initiatives by governments and private organizations to increase funding for cytokine research present lucrative opportunities for market players. However, high production costs and technical limitations of cytokine production techniques continue to hamper market potential. Short shelf-life and poor stability of cytokines also challenge wider commercialization.

Key Features of the Study:

This report provides in-depth analysis of the global cytokine market and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global cytokine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Abbott, AB Sciex, Agilent Technologies Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Quest Diagnostics Inc, Danaher, DiaSorin S.p.A, Immunodiagnostic Systems, Fujirebio, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global cytokine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cytokine market

Market Segmentation

• Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Tumor Necrosis Factor-TNF
  • Interleukins-II
  • Interferons-IFN
  • Epidermal Growth Factor-EGF
  • Others
• Therapeutic Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Cancer
  • Asthma
  • Arthritis
  • Hematology
  • Others
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals
  • Research laboratories
  • Others
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Abbott
  • AB Sciex
  • Agilent Technologies Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • DiaSorin S.p.A.
  • Hoffmann-La Roche Ltd.
  • Quest Diagnostics Inc
  • Danaher
  • DiaSorin S.p.A
  • Immunodiagnostic Systems
  • Fujirebio, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Cytokine Market, By Type
  • Cytokine Market, By Therapeutic Application
  • Cytokine Market, By End User
  • Cytokine Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Cytokine Market, By Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Tumor Necrosis Factor-TNF
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Interleukins-II
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Interferons-IFN
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Epidermal Growth Factor-EGF
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Cytokine Market, By Therapeutic Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Asthma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Arthritis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hematology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Cytokine Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Research laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Cytokine Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AB Sciex
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Agilent Technologies Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• bioMerieux SA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• DiaSorin S.p.A.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• F.Hoffmann-La Roche Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Quest Diagnostics Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Danaher
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• DiaSorin S.p.A
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Immunodiagnostic Systems
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Fujirebio, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

9. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us